Literature DB >> 11091539

Higher Level of P-glycoprotein Expression in Human Breast Cancer Cells after Radiation Therapy.

.   

Abstract

We investigated the effects of radiation on the expression of p53 protein and P-gp in breast cancer cells. Thirty-two preoperatively irradiated surgical specimens of stage I primary breast cancer were examined, and 39 surgical specimens of non-irradiated stage I breast cancer were selected as a control group. p53 and P-gp expression was detected by an immunohistochemical technique using rabbit polyclonal antibodies (RSP-53 and NCL-pGLYPp). The expression of p53 protein, defined as a nuclear immunoreaction in 20% or more of tumor cells, was detected in 4(13%) of the 32 cases in the irradiated group and 7 (18%) of the 39 cases in the non-irradiated group without any statistically significant difference. The expression of P-gp, defined as the presence of strong staining in more than 75% of the tumor cells, was detected in 19 (59%) of the cases in the irradiated group and 12(31%) of the cases in the non-irradiated group. P-gp expression was significantly higher in the former group than in the latter (P <0.05). There was no significant difference in P-gp expression between the stromal invasive component and the intraductal component in either the irradiated or the non-irradiated group. Radiotherapy possibly induces membranous P-gp expression in human breast cancer cells.

Entities:  

Year:  1995        PMID: 11091539     DOI: 10.1007/BF02966947

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  26 in total

Review 1.  Combined modality therapy of head and neck cancer.

Authors:  R Stupp; R R Weichselbaum; E E Vokes
Journal:  Semin Oncol       Date:  1994-06       Impact factor: 4.929

2.  Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents.

Authors:  M Fritsche; C Haessler; G Brandner
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

3.  Expression of P-glycoprotein-mediated drug resistance in CHO cells surviving a single X-ray dose of 30 Gy.

Authors:  S McClean; L K Hosking; B T Hill
Journal:  Int J Radiat Biol       Date:  1993-06       Impact factor: 2.694

4.  Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy.

Authors:  S J Schnitt; J L Connolly; U Khettry; G Mazoujian; M Brenner; B Silver; A Recht; G Beadle; J R Harris
Journal:  Cancer       Date:  1987-02-15       Impact factor: 6.860

5.  p53 as an independent prognostic marker in lymph node-negative breast cancer patients.

Authors:  R Silvestrini; E Benini; M G Daidone; S Veneroni; P Boracchi; V Cappelletti; G Di Fronzo; U Veronesi
Journal:  J Natl Cancer Inst       Date:  1993-06-16       Impact factor: 13.506

Review 6.  Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy.

Authors:  M S Anscher; P Jones; L R Prosnitz; W Blackstock; M Hebert; R Reddick; A Tucker; R Dodge; G Leight; J D Iglehart
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

7.  High levels of p53 protein in UV-irradiated normal human skin.

Authors:  P A Hall; P H McKee; H D Menage; R Dover; D P Lane
Journal:  Oncogene       Date:  1993-01       Impact factor: 9.867

8.  Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

Authors:  K V Chin; K Ueda; I Pastan; M M Gottesman
Journal:  Science       Date:  1992-01-24       Impact factor: 47.728

9.  A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors.

Authors:  B Fisher; C Redmond; N V Dimitrov; D Bowman; S Legault-Poisson; D L Wickerham; N Wolmark; E R Fisher; R Margolese; C Sutherland
Journal:  N Engl J Med       Date:  1989-02-23       Impact factor: 91.245

10.  The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.

Authors:  R L Zastawny; R Salvino; J Chen; S Benchimol; V Ling
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

View more
  1 in total

Review 1.  Summary of information on the effects of ionizing and non-ionizing radiation on cytochrome P450 and other drug metabolizing enzymes and transporters.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Curr Drug Metab       Date:  2012-07       Impact factor: 3.731

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.